Isolation and identification of cross-reactive T cells

Details Isolation and identification of cross-reactive T cells Isolation and identification of cross-reactive T cells

2011-07-05

2011-07-05

Juedes, Amy E (Department: 1644)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Primate cell, per se

C530S327000

Reexamination Certificate

active

07972848

ABSTRACT:
Cross-reactive T cells recognizing both MBP93-105and HHV-61-13peptides represent a significant subset of T cells with some degree of TCR degeneracy. It appears that the recognition of the cross-reactive T cells has a less stringent requirement for the flanking residues of the two peptides. In contrast, these flanking residues are critical for the T cell recognition of mono-specific T cells. The association between HHV-6 and autoreactive immune responses to MBP indicates that cross-reactive T cells, peptides from the V-D-J region of the T cell receptor from autoreactive T cells, and antiviral agents may prevent or treat MS.

REFERENCES:
patent: 4683202 (1987-07-01), Mullis
patent: 5614192 (1997-03-01), Vandenbark
patent: 6303314 (2001-10-01), Zhang
patent: 7658926 (2010-02-01), Zhang
patent: WO 99/13904 (1999-03-01), None
Cirone et al., 2002, J. Med. Vir. vol. 68: 268-272.
Zhang et al., 1996, J. Mol. Med. vol. 74: 653-662.
Brosterhus et al., 1999, Eur. J. Immunol. vol. 29: 4053-4059.
Tejada-Simon et al., 2001, Eur. J. Immunol. vol. 31: 907-917.
Tejada-Simon et al., 2003, Ann Neurol. vol. 53: 189-197.
Ben-Nun, et al., “Vaccination against autoimmune encephalomyelitis with T-lymphocite line cells reactive against myelin basic protein,” Nature, 292:60-61 (1981).
Challoner, P.B., et al., “Plaque-associated expression of human herpesvirus 6 in multiple sclerosis,” Proc. Natl. Acad. Sci., USA, 92:7440-44 (1995).
Cirone, M., et al., “Human Herpesvirus 6 and Multiple Sclerosis: A Study of T Cell Cross-Reactivity to Viral and Myelin Basic Protein Antigens,” J. Med. Virol., 68:268-272 (2002).
Hong, et al., J. Immunol., 163:3530-3538 (1999).
Lider, et al., Science, 239:181-83 (1988).
Lohse, et al., Science, 244:820-822 (1989).
U.S. Appl. No. 60/386,287, filed May 6, 2002, Zhang, Jingwu Z.
U.S. Appl. No. 60/405,521, filed Aug. 23, 2002, Mattern, Rene.
Medaer, et al., “Depletion of myelin-basic-protein autoreactive T cells by T-cell vaccination: pilot trial in multiple sclerosis,” Lancet, 346:807-808 (1995).
Stinissen, P., et al., “gammadelta T Cell Responses to Activated T Cells in Multiple Sclerosis Patients Induced by T Cell Vaccination,” J. of Neuroimmunology, 87:94-104 (1998).
Stinissen, P., et al., “Vaccination with Autoreactive T Cell Clones in Multiple Sclerosis: Overview of Immunological and Clinical Data,” J. of Neuroscience Research, 45(4):500-511 (1996).
Supplementary European Search Report of EP 03 80 0185 dated Jan. 9, 2006.
Tejada-Simon, M., et al., “Cross-Reactivity with Myelin Basic Protein and Human Herpesvirus-6 in Multiple Sclerosis,” Annals of Neurology, 53(2):189-197 (2003).
Tejada-Simon, M., et al., “Detection of Viral DNA and Immune Responses to the Human Herpesvirus 6 101-Kilodalton Virion Protein in Patients with Multiple Sclerosis and in Controls,” J. Virol., 76(12):6147-6154 (2002).
Vandevyer, et al., Eur. J. Immunol., 25:958-968 (1995).
Wucherpfennig, et al., J. Immunol., 152:5581-5592 (1994).
Zang, et al., “Restricted TCR V* gene rearrangements in T cells recongizing an immunodominant peptide of myelin basic protein in DR2 patients with multiple sclerosis,” Intern Immunol. 10:991-998 (1998).
Zhang, et al., “T cell vaccination in multiple sclerosis: results of a preliminary study,” J. Neurol., 249:212-8 (2002).
Zhang, J., et al., “MHC-Restricted Depletion of Human Myelin Basic Protein-Reactive T Cells by T Cell Vaccination,” Science, 261:1451-1454 (1993).
Zhang, J., et al., “T Cell Vaccination: Clinical Application in Autoimmune Diseases,” J. of Molecular Medicine, 74(11):653-662 (1996).

Affiliated with

Also associated with

Rating

Isolation and identification of cross-reactive T cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Isolation and identification of cross-reactive T cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolation and identification of cross-reactive T cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2635143